These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1861581)

  • 1. Cancer immunotherapy. Part II: New approaches.
    Elias EG
    Md Med J; 1991 Jun; 40(6):525-6. PubMed ID: 1861581
    [No Abstract]   [Full Text] [Related]  

  • 2. How can chemoimmunotherapy best be used for the treatment of colon cancer?
    Medina-Echeverz J; Berraondo P
    Immunotherapy; 2012 Dec; 4(12):1787-90. PubMed ID: 23240744
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adjuvant treatment of colonic cancer. An important progress?].
    Burtin P; Cosset JM
    Bull Cancer; 1990; 77(8):753-7. PubMed ID: 2207364
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adjuvant treatment in operable colonic and rectal cancer. A new possibility].
    Tveit KM
    Tidsskr Nor Laegeforen; 1997 Aug; 117(20):2991-2. PubMed ID: 9340862
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reevaluation of immunopotentiation therapy for cancer].
    Toyoshima K
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):817-23. PubMed ID: 10897207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy for colo-rectal cancer.
    Wilson RE
    Ann Chir Gynaecol; 1983; 72(6):290-2. PubMed ID: 6364949
    [No Abstract]   [Full Text] [Related]  

  • 7. Active specific immunotherapy and immunochemotherapy in the treatment of lung and colon cancer.
    Hollinshead A
    Semin Surg Oncol; 1991; 7(4):199-210. PubMed ID: 1925251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic and immunotherapeutic aspects of colonic carcinoma].
    Arnoldi E
    Ann Ital Chir; 1990; 61(5):495-8. PubMed ID: 2100967
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukins and colon cancer.
    Caro-Patón Gómez A
    Rev Esp Enferm Dig; 2005 Sep; 97(9):613-8. PubMed ID: 16266233
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor efficacies of maltose tetrapalmitate immunotherapy alone and in combinations with radiotherapy and with cyclophosphamide chemotherapy against dimethylhydrazine induced colon and anal cancers in CDI mice.
    Benrezzak O; Madarnas P; Pageau R; Nigam VN
    Anticancer Res; 1988; 8(3):499-506. PubMed ID: 3389753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapeutic approaches for renal cancer.
    Pizza G; de Vinci C; Viza D
    Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765
    [No Abstract]   [Full Text] [Related]  

  • 12. Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors.
    Daftarian P; Song GY; Ali S; Faynsod M; Longmate J; Diamond DJ; Ellenhorn JD
    Cancer Res; 2004 Aug; 64(15):5407-14. PubMed ID: 15289349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy of cancer using levamisole, immunologic control of the post-surgical patient and graphic follow-up].
    de Carli HO; Llargues JM
    Rev Esp Oncol; 1980; 27(1):67-80. PubMed ID: 7209109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunotherapy and immunoprophylaxis of bladder cancer].
    Figurin KM; Tsiganu VI
    Urol Nefrol (Mosk); 1993; (4):46-9. PubMed ID: 8310570
    [No Abstract]   [Full Text] [Related]  

  • 15. Loco-regional immunotherapy for bladder cancer.
    Kuss R; Haertig A
    Prog Clin Biol Res; 1984; 162B():321-33. PubMed ID: 6504902
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunotherapy with leakadin in the combined therapy of acoustic neurinomas].
    Khil'ko VA; Lantsov AA; Gorokhov AA; Starchenko AA; Komarets SA; Khlunovskiĭ AN
    Vestn Otorinolaringol; 1994; (2):17-9. PubMed ID: 7855992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Which adjuvant treatments and what are their indications following resection for cure in colonic cancer?].
    Rougier P; Seitz JF
    Gastroenterol Clin Biol; 1998 Mar; 22(3 Suppl):S131-46. PubMed ID: 9762250
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
    Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
    Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
    Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant immunotherapy in colorectal cancer.
    Vermorken JB
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):66-71. PubMed ID: 11049049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.